Evidence map›Paper›PMID 31958143›Full record

ArticleThe British journal of dermatology2020

Association of IRF4 single-nucleotide polymorphism rs12203592 with melanoma-specific survival.

S V Ward, D C Gibbs, I Orlow, N E Thomas, P A Kanetsky, L Luo, A E Cust, H Anton-Culver, S B Gruber, R P Gallagher and 6 more

Open access · greenAbstract readLetter
In one paragraph

Article in The British journal of dermatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 11 institutions in 5 countries.

S V WardCentre for Genetic Origins of Health and Disease, School of Biomedical Sciences, The University of Western Australia, Perth, WA, Australia.ORCID 0000-0002-9799-6734
D C GibbsEmory University, Atlanta, GA, U.S.A.
I OrlowMemorial Sloan Kettering Cancer Center, New York, NY, U.S.A.
N E ThomasUniversity of North Carolina, Chapel Hill, NC, U.S.A.
P A KanetskyH. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, U.S.A.
L LuoUniversity of New Mexico, Albuquerque, NM, U.S.A.
A E CustThe University of Sydney, Sydney, NSW, Australia.ORCID 0000-0002-5331-6370
H Anton-CulverUniversity of California, Irvine, CA, U.S.A.
S B GruberCity of Hope National Medical Center, Duarte, CA, U.S.A.
R P GallagherUniversity of British Columbia, Vancouver, BC, Canada.
S RossoPiedmont Cancer Registry, Turin, Italy.
R ZanettiPiedmont Cancer Registry, Turin, Italy.
T DwyerUniversity of Oxford, Oxford, U.K.
C B BeggMemorial Sloan Kettering Cancer Center, New York, NY, U.S.A.
M BerwickUniversity of New Mexico, Albuquerque, NM, U.S.A.
GEM Study Group
Memorial Sloan Kettering Cancer Center · USPiedmont Reference Center for Epidemiology and Cancer Prevention · ITUniversity of New Mexico · USCity Of Hope National Medical Center · USEmory University · USMoffitt Cancer Center · USThe University of Sydney · AUUniversity of British Columbia · CAUniversity of California, Irvine · USUniversity of North Carolina at Chapel Hill · USUniversity of Oxford · GB

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
WOMEN'S CANCERS RESEARCH PROGRAMP30CA118100 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Yolanda Sanchez · 2005 to 2026
$57.1M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM008169 · NIGMS · EMORY UNIVERSITY · PI GROSS, ROBERT E · 1987 to 2021
$20.3M
Sex Differences in Methylome Alterations and Mutational Burden in Early Stage MelanomaP01CA206980 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI BERWICK, MARIANNE, THOMAS, NANCY E. · 2017 to 2022
$10.1M
Melanoma RAS/BRAF Mutation:Heterogeneity-Risk-PrognosisR01CA112243 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI THOMAS, NANCY E. · 2005 to 2014
$5.4M
A MODEL FOR GENETIC SUSCEPTIBILITY: MELANOMAU01CA083180 · NCI · UNIVERSITY OF NEW MEXICO · PI BERWICK, MARIANNE · 1999 to 2003
$5.2M
Identification of Lethal Melanomas at the Time of DiagnosisR01CA233524 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ANTON-CULVER, HODA A, BEGG, COLIN B · 2020 to 2024
$4.5M
Solar Exposure and Melanoma SurvivalR01CA112524 · NCI · UNIVERSITY OF NEW MEXICO · PI BERWICK, MARIANNE · 2005 to 2009
$2.5M
Epidemiologic Parameters of Rare Cancer Risk FactorsR01CA098438 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI BEGG, COLIN B · 2003 to 2005
$839k
Validation of the use of whole-genome amplified DNA in a population-based studyR03CA173806 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI ORLOW, IRENE · 2013 to 2014
$170k
Mutational Analysis of Clonality in Multiple Primary MelanomaR03CA125829 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI ORLOW, IRENE · 2006 to 2007
$128k
Cancer Institute NSW 15/CDF/1-14National Health and Medical Research Council 1121242National Health and Medical Research Council 1147843NCI NIH HHS P01 CA206980NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA118100NCI NIH HHS R01 CA098438NCI NIH HHS R01 CA112243NCI NIH HHS R01 CA112524NCI NIH HHS R01 CA233524NCI NIH HHS R03 CA125829NCI NIH HHS R03 CA173806NCI NIH HHS U01 CA083180NIGMS NIH HHS T32 GM008169
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Interferon Regulatory FactorsMelanomaSkin NeoplasmsGenetic Predisposition to DiseaseGenotypeHumansInterferon Regulatory Factor-4Polymorphism, Single NucleotideSurvival RateInterferon Regulatory Factor-4Interferon Regulatory Factors

Identifiers

PMID31958143
PMCPMC7334062
OpenAlexW3003012572

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.